Microchip Technology Inc. (NASDAQ:MCHP) Q2 2023 Earnings Conference Call November 3, 2022 5:00 PM ET Company Participants Ganesh Moorthy - President & Chief Executive Officer James Eric Bjornholt - Senior Vice President & Chief Financial Officer Stephen Sanghi - Executive Chair Conference Call Participants Ambrish Srivastava - BMO Vivek Arya - Bank of America Securities Christopher Rolland - Susquehanna Timothy Arcuri - UBS William Stein - Truist Securities Chris Danely - Citigroup Toshiya Hari - Goldman Sa ...

Microchip Technology Incorporated (NASDAQ:MCHP) Q1 2023 Earnings Conference Call August 2, 2022 5:00 PM ET Company Participants Eric Bjornholt ??? Chief Financial Officer Ganesh Moorthy ??? President and Chief Executive Officer Steve Sanghi ??? Executive Chair Sajid Daudi ??? Head-Investor Relations Conference Call Participants Gary Mobley ??? Wells Fargo Raji Gil ??? Needham & Company John Buchalter ??? Cowen William Stein ??? Truist Securities Chris Danely ??? Citi Harlan Sur ??? J.P. Morgan Tore Svanberg ...

A Leading Provider of Smart, Connected and Secure Embedded Solutions Investor Presentation First Quarter Fiscal Year 2023 Leading Provider of Smart, Connected, and Secure Embedded Control Solutions SAFE HARBOR Forward Looking Statement Safe Harbor: During the course of this presentation, we will make projections or other forward-looking statements regarding the future financial performance of the company (including our guidance) or future events, including our strategy, growth drivers, industry outlook, ind ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number: 0-21184 MICROCHIP TECHNOLOGY INCORPORATED (Exact Name of Registrant as Specified in Its Charter) Delaware 86-0 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended March 31, 2022 OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from _________ to __________ MICROCHIP TECHNOLOGY INCORPORATED (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation or Orga ...

Microchip Technology Incorporated (NASDAQ:MCHP) Q4 2022 Earnings Conference Call May 9, 2022 5:00 PM ET Company Participants Eric Bjornholt - CFO Ganesh Moorthy - CEO Steve Sanghi - Executive Chair Conference Call Participants Joe Moore - Morgan Stanley Gary Mobley - Wells Fargo Securities Vivek Arya - Bank of America Tore Svanberg - Stifel Chris Caso - Raymond James Chris Danely - Citi William Stein - Truist Securities Harsh Kumar - Piper Sandler Christopher Rolland - Susquehanna Harlan Sur - JPMorgan Pra ...

Microchip Technology Incorporated (NASDAQ:MCHP) Q3 2022 Earnings Conference Call February 3, 2022 5:00 PM ET Company Participants Eric Bjornholt - Chief Financial Officer Ganesh Moorthy - President and Chief Executive Officer Steve Sanghi - Executive Chair Sajid Daudi - Head, Investor Relations Conference Call Participants John Pitzer - Credit Suisse Pradeep Ramani - UBS Gary Mobley - Wells Fargo Securities Toshiya Hari - Goldman Sachs Vivek Arya - Bank of America Securities Harlan Sur - JPMorgan Harsh Kuma ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number: 0-21184 MICROCHIP TECHNOLOGY INCORPORATED (Exact Name of Registrant as Specified in Its Charter) (State or ...

Microchip Technology Incorporated (NASDAQ:MCHP) Q2 2022 Earnings Conference Call November 5, 2021 5:00 PM ET Company Participants Ganesh Moorthy ??? President and Chief Executive Officer Steve Sanghi ??? Executive Chair Eric Bjornholt ??? Chief Financial Officer Sajid Douty ??? Head of Investor Relations Conference Call Participants John Pitzer ??? Credit Suisse Gary Mobley ??? Wells Fargo Vivek Arya ??? Bank of America Securities Tore Svanberg ??? Stifel Prajib Rahmani ??? UBS Matt Ramsay ??? Cowen Harlan ...

Supply Chain and Manufacturing - The company anticipates that certain supply chain constraints will continue through calendar 2022 and possibly beyond [82]. - The expectation is that days of inventory at December 31, 2021, will be between 112 to 118 days [82]. - The company plans to continue operating manufacturing facilities at or above normal capacity if current supply constraints relative to demand persist [85]. - The company launched a Preferred Supply Program in Q4 of fiscal 2021, providing prioritized capacity for customers with a 12-month continuous backlog [97]. - The company expects wafer fabrication, assembly, and test constraints to persist through calendar 2022 and possibly beyond [97]. - The company has added assembly and test capacity to increase manufacturing capability [91]. Financial Performance - Net sales for the three months ended September 30, 2021, were $1,649.8 million, a 26.0% increase from $1,309.5 million in the same period of 2020 [102]. - For the six months ended September 30, 2021, net sales reached $3,219.2 million, up 22.9% from $2,619.2 million in the prior year [102]. - Gross profit margin improved to 64.8% for the three months ended September 30, 2021, compared to 61.7% in the same period of 2020 [100]. - Operating income for the three months ended September 30, 2021, was 25.2%, significantly higher than 17.3% in the same period of 2020 [100]. - Gross profit for the three months ended September 30, 2021 was $1.07 billion, or 64.8% of net sales, compared to $807.9 million, or 61.7% of net sales for the same period in 2020 [123]. - Gross profit for the six months ended September 30, 2021 was $2.08 billion, or 64.5% of net sales, compared to $1.61 billion, or 61.3% of net sales for the same period in 2020 [123]. Product Performance - Microcontroller product line accounted for 54.1% of net sales in the three months ended September 30, 2021, increasing from 53.7% in the same period of 2020 [108]. - Analog product line sales increased by 35.7% in the three months ended September 30, 2021, compared to the same period in 2020 [112]. - The average selling price of microcontroller products has remained stable, with expectations to moderate price declines through new product introductions [110]. - Sales in Asia accounted for 54.9% of total net sales for the three months ended September 30, 2021, compared to 55.5% in the same period of 2020 [120]. Expenses and Investments - R&D expenses for the three months ended September 30, 2021 were $246.2 million, or 14.9% of net sales, compared to $199.8 million, or 15.3% of net sales for the same period in 2020 [131]. - R&D expenses increased by $46.4 million, or 23.2%, for the three months ended September 30, 2021 compared to the same period last year [132]. - Selling, general and administrative expenses for the three months ended September 30, 2021 were $179.9 million, or 10.9% of net sales, compared to $144.7 million, or 11.1% of net sales for the same period in 2020 [134]. - Selling, general and administrative expenses increased by $35.2 million, or 24.3%, for the three months ended September 30, 2021 compared to the same period last year [135]. - Capital expenditures for the six months ended September 30, 2021, were $164.8 million, significantly up from $15.8 million in the same period of 2020, aimed at expanding production capacity and R&D [152]. - The company expects to invest between $350.0 million and $450.0 million in equipment and facilities over the next twelve months to support growth and in-house operations [152]. Cash Flow and Debt - As of September 30, 2021, the company had $255.3 million in cash, cash equivalents, and short-term investments, a decrease of $26.7 million from March 31, 2021 [149]. - Net cash provided by operating activities was $1.24 billion for the six months ended September 30, 2021, compared to $957.6 million for the same period in 2020, primarily due to higher net sales [150]. - Net cash used in financing activities was $1.06 billion for the six months ended September 30, 2021, compared to $931.7 million for the same period in 2020 [153]. - As of September 30, 2021, the principal amount of outstanding indebtedness was $8.41 billion, with $1.81 billion drawn from the Revolving Credit Facility [154]. - Long-term debt totaled $8.41 billion as of September 30, 2021, with $6.60 billion being fixed-rate debt and $1.81 billion being variable-rate debt [161]. - A 50 basis point increase in interest rates would increase expected annual interest expense by approximately $9.0 million [161]. - The company intends to maintain liquidity through existing cash balances and cash flows from operations for at least the next 12 months [160]. Health and Safety - The company believes that its actions to combat COVID-19 will help preserve the health of its team members and allow safe operations [90]. - The company is working with government authorities to ensure compliance with regulations and safeguard its workforce [91].